113 related articles for article (PubMed ID: 32380461)
1. Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non-Small Cell Lung Cancer.
Milligan MG; Cronin AM; Colson Y; Kehl K; Yeboa DN; Schrag D; Chen AB
J Natl Compr Canc Netw; 2020 May; 18(5):547-554. PubMed ID: 32380461
[TBL] [Abstract][Full Text] [Related]
2. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
Balekian AA; Fisher JM; Gould MK
Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer.
Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
[TBL] [Abstract][Full Text] [Related]
4. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
[TBL] [Abstract][Full Text] [Related]
5. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
6. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
[TBL] [Abstract][Full Text] [Related]
7. No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer.
Nam JG; Hong H; Choi SH; Park CM; Goo JM; Kim YT; Kim H
Radiology; 2022 Jun; 303(3):632-643. PubMed ID: 35258373
[TBL] [Abstract][Full Text] [Related]
8. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
Rice SR; Molitoris JK; Vyfhuis MAL; Edelman MJ; Burrows WM; Feliciano J; Nichols EM; Suntharalingam M; Donahue J; Carr SR; Friedberg J; Badiyan S; Simone CB; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2019 Jan; 20(1):e107-e114. PubMed ID: 30337268
[TBL] [Abstract][Full Text] [Related]
10. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
[TBL] [Abstract][Full Text] [Related]
11. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
12. Receipt of recommended surveillance with imaging in elderly survivors of early stage non-small cell lung cancer.
Malhotra J; Rotter D; Jabbour SK; Aisner J; Lin Y; Manne S; Demissie K
Lung Cancer; 2018 Nov; 125():205-211. PubMed ID: 30429021
[TBL] [Abstract][Full Text] [Related]
13. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.
Ko KH; Hsu HH; Huang TW; Gao HW; Cheng CY; Hsu YC; Chang WC; Chu CM; Chen JH; Lee SC
Medicine (Baltimore); 2015 Jan; 94(3):e434. PubMed ID: 25621697
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer].
Ozgül MA; Uysal MA; Kadakal F; Altoparlak B; Cinemre H; Yilmaz V
Tuberk Toraks; 2006; 54(3):229-34. PubMed ID: 17001539
[TBL] [Abstract][Full Text] [Related]
16. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
17. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
18. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
19. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
